Neuropharmacologic analysis of AHR-2277 a new psychotherapeutic agent.
D000679:Amygdala / Q000502:physiology; D000818:Animals; D000927:Anticonvulsants; D001362:Avoidance Learning / Q000187:drug effects; D002090:Butyrophenones / Q000494:pharmacology*; D002415:Cats; D002540:Cerebral Cortex / Q000502:physiology; D002746:Chlorpromazine / Q000494:pharmacology*; D003441:Crowding; D004569:Electroencephalography; D005071:Evoked Potentials; D005260:Female; D006220:Haloperidol / Q000494:pharmacology*; D006624:Hippocampus / Q000502:physiology; D008297:Male; D051379:Mice; D010880:Piperidines / Q000494:pharmacology*; D014149:Tranquilizing Agents / Q000494:pharmacology*
D000927:Anticonvulsants; D002090:Butyrophenones; D010880:Piperidines; D014149:Tranquilizing Agents; D006220:Haloperidol; D002746:Chlorpromazine